Viewing Study NCT03674567

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:53 AM
Ignite Modification Date: 2026-02-27 @ 4:00 AM
Study NCT ID: NCT03674567
Status: COMPLETED
Last Update Posted: 2025-01-24
First Post: 2018-09-14
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination with Pembrolizumab
Sponsor: RAPT Therapeutics, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non-small Cell Lung Cancer View
None Head and Neck Squamous Cell Carcinoma View
None Breast Cancer View
None Urothelial Carcinoma View
None Nasopharyngeal Carcinoma View
None Cervical Cancer View
None Lymphoma View